欧洲寡核苷酸合成市场到 2027 年 - 按产品（合成寡核苷酸、试剂和设备）、应用（研究、诊断和治疗）、最终用户（学术研究机构、制药和生物技术公司、诊断实验室等）进行区域分析和预测终端用户）
No. of Pages: 163 | Report Code: TIPRE00007128 | Category: Life Sciences
No. of Pages: 163 | Report Code: TIPRE00007128 | Category: Life Sciences
欧洲寡核苷酸合成市场预计将从 2018 年的 5.1802 亿美元增至 2027 年的 12.7095 亿美元。预计从 2019 年开始，该市场将以 13.7% 的复合年增长率增长-2027。
市场的增长是由以下因素推动的：研究和学术大学正在与商业市场参与者合作开发技术并简化人工 DNA 合成的方法，以及市场参与者数量的增加及其对寡核苷酸合成的关注可能会促进寡核苷酸的增长预测期内该地区的合成。
合成DNA广泛应用于生物学。寡核苷酸被用于许多生物学和法医学应用，因为序列特异性结合剂可以帮助识别特定目标 DNA 序列的存在。合成寡核苷酸是通过化学合成组装的短链单链 DNA 片段。由于快速高效合成寡核苷酸方法的同步发展和分子生物学技术的出现。
寡核苷酸在以下领域有许多应用：研究、疾病诊断、治疗、法医、药物发现、农业等等。合成寡核苷酸广泛用于人类遗传疾病的诊断。此外，英国寡核苷酸合成市场的参与者一直在获得资金以增强其产品供应。例如，2019 年 3 月，英国私营生物技术公司 Procarta Biosystems 从 Novo Holdings REPAIR Impact Fund 获得了 169 万美元（150 万欧元）的资金，以开发对抗抗菌药物的新疗法抗性（AMR）。
研究人员还使用寡核苷酸来进行更高效、更环保的化学合成。通过将寡核苷酸组装成编码合成基因的较长片段，可以指示细菌或酵母细胞产生特定的酶（一种蛋白质）。
寡核苷酸还具有广泛的潜力治疗各种医疗状况。它们使得治疗方法的开发成为可能，因为可以靶向、操纵、沉默和/或调节故障基因。例如，Ionis Pharmaceuticals 致力于寡核苷酸治疗药物的开发，特别是反义寡核苷酸 (ASO) 治疗药物。因此，合成寡核苷酸在各个领域的广阔前景推动了市场的增长。
;
由于私营企业之间的伙伴关系和合作数量不断增加，专门用于生物技术公司以及基因合成学术和研究机构的投资和资金不断增加，西班牙预计将引领欧洲地区的市场基于最终产品。因此，考虑到上述因素，在预测期内，该国市场的增长可能会在欧洲地区贡献最大份额。
图：意大利寡核苷酸合成市场收入及 2027 年预测（百万美元）
<跨度>
欧洲寡核苷酸合成——市场细分
按产品
< p>
由
最终用户
按地理位置
公司简介
Strategic insights for Europe Oligonucleotide Synthesis involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 518.02 Million |
| Market Size by 2027 | US$ $ 1,270.95 Million |
| Global CAGR (2019 - 2027) | 13.7% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Oligonucleotide Synthesis refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies
The Europe Oligonucleotide Synthesis Market is valued at US$ 518.02 Million in 2018, it is projected to reach US$ $ 1,270.95 Million by 2027.
As per our report Europe Oligonucleotide Synthesis Market, the market size is valued at US$ 518.02 Million in 2018, projecting it to reach US$ $ 1,270.95 Million by 2027. This translates to a CAGR of approximately 13.7% during the forecast period.
The Europe Oligonucleotide Synthesis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Oligonucleotide Synthesis Market report:
The Europe Oligonucleotide Synthesis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Oligonucleotide Synthesis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Oligonucleotide Synthesis Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Oligonucleotide Synthesis Market
